FAST TRACK FOR DRUG SLOWING ALZHEIMER'S!
National Enquirer|February 13, 2023
A NEW drug to treat Alzheimer's disease was fast-tracked for approval by the U.S. Food and Drug Administration (FDA), arming physicians with another weapon in their fight against the memory robbing condition! Lecanemab, which is being marketed as Leqsebi, is not a cure.
FAST TRACK FOR DRUG SLOWING ALZHEIMER'S!

But it appears to slow disease progression by reducing amyloid-beta plaque damaging protein clumps found in the brains of folks with Alzheimer's.

Dr. Billy Dunn, director of the FDA's Office of Neuroscience, says, "This is the latest therapy to target and affect the underlying disease process instead of only treating the symptoms."

この記事は National Enquirer の February 13, 2023 版に掲載されています。

7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。

この記事は National Enquirer の February 13, 2023 版に掲載されています。

7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。